{
  "id": 1435,
  "text": "1 3 \\ – 1 .3 1$ ), respectively).Evaluating the efficacy and safety of cisplatin-based CCRT in patients with high-risk cervical carcinoma compared with exclusive radiotherapy, the meta-analysis published by Meng et $a l .",
  "ChatGPT_query": "Please create a <question> that closely aligns with the provided <text>. Ensure that the <question> is formulated in Chinese and does not explicitly reference the text. You may incorporate specific scenarios or contexts in the <question>, allowing the <text> to serve as a comprehensive and precise answer.\n\n<text>: 1 3 \\ – 1 .3 1$ ), respectively).Evaluating the efficacy and safety of cisplatin-based CCRT in patients with high-risk cervical carcinoma compared with exclusive radiotherapy, the meta-analysis published by Meng et $a l .\n\n<question>: \n\n**如果text中内容跟宫颈癌无关，请回复'SKIP'**\n",
  "ChatGPT_response_0": "根据研究，高危宫颈癌患者接受顺铂联合同步放化疗（CCRT）相比单纯放疗显示出更显著的治疗效果和总体生存率提升。顺铂作为标准化疗药物，能增强放疗的敏感性，同时显著降低局部复发的风险。然而，在安全性方面，CCRT可能导致更多的化疗相关副作用，如恶心、呕吐和骨髓抑制，需要在治疗过程中密切监测患者状况，以平衡治疗收益和风险。因此，对于高危宫颈癌患者，CCRT是一种更为有效的治疗方案，但需结合患者个体情况综合评估后决定治疗策略。",
  "query": "宫颈癌患者接受顺铂联合同步放化疗(CCRT)是否比仅接受放疗安全有效？",
  "ChatGPT_query_a": "You are HuatuoGPT-II, equipped with in-depth knowledge in medicine. Your task is to directly answer the user's <question> in Chinese. In formulating your response, you must thoughtfully reference the <reference text>, ensuring that your reply does not disclose your reliance on <reference text>. Aim to provide a comprehensive and informative response, incorporating relevant insights from <reference text> to best assist the user. Please be cautious to avoid including any content that might raise ethical concerns.\n\n<question>: 宫颈癌患者接受顺铂联合同步放化疗(CCRT)是否比仅接受放疗安全有效？\n\n<reference text>: 1 3 \\ – 1 .3 1$ ), respectively).Evaluating the efficacy and safety of cisplatin-based CCRT in patients with high-risk cervical carcinoma compared with exclusive radiotherapy, the meta-analysis published by Meng et $a l .\n\n**如果text中内容跟宫颈癌无关，请回复'SKIP'**\n\n<reply>: ",
  "response": "根据研究，高危宫颈癌患者接受顺铂联合同步放化疗（CCRT）相比单纯放疗显示出更显著的治疗效果和总体生存率提升。顺铂作为标准化疗药物，能增强放疗的敏感性，同时显著降低局部复发的风险。然而，在安全性方面，CCRT可能导致更多的化疗相关副作用，如恶心、呕吐和骨髓抑制，需要在治疗过程中密切监测患者状况，以平衡治疗收益和风险。因此，对于高危宫颈癌患者，CCRT是一种更为有效的治疗方案，但需结合患者个体情况综合评估后决定治疗策略。"
}